ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - formoterol fumarate dihydrate 4.5 mcg/actuation; budesonide 160 mcg/actuation - formoterol and budesonide

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - budesonide; formoterol fumarate dihydrate - אבקה לשאיפה - budesonide 100 mcg/dose; formoterol fumarate dihydrate 6 mcg/dose - formoterol and budesonide

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - budesonide; formoterol fumarate dihydrate - אבקה לשאיפה - budesonide 200 mcg/dose; formoterol fumarate dihydrate 6 mcg/dose - formoterol and budesonide

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - budesonide; formoterol fumarate dihydrate - אבקה לשאיפה - budesonide 400 mcg/dose; formoterol fumarate dihydrate 12 mcg/dose - formoterol and budesonide

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - formoterol fumarate - אבקה לשאיפה - formoterol fumarate 9 mcg/dose - formoterol - formoterol - for the relief of broncho-obstructive symptoms and prevention of exercise-induced symptoms in asthmatics when adequate treatment with corticosteroids is not sufficient. for the relief of bronco-obstructive symptoms in patients with chronic obstructive pulmonary disease (copd).

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - formoterol fumarate - אבקה לשאיפה - formoterol fumarate 9 mcg/dose - formoterol - formoterol - for the relief of broncho-obstructive symptoms and prevention of exercise-induced symptoms in asthmatics when adequate treatment with corticosteroids is not sufficient for the relief of bronco-obstructive symptoms in patients with chronic obstructive pulmonary disease (copd).